Why the study?
Is β-adrenergic receptor-mediated vasodilation preserved in young adults with obesity compared to normal weight adults?
Is β-adrenergic receptor-mediated vasodilation preserved in young adults with obesity compared to normal weight adults?
Subclinical changes in microvascular control mechanisms occur early in obesity, but β-adrenergic-mediated vasodilation remains preserved in young, healthy adults.
Supports preserved β-adrenergic vasodilation early in obesity; hypothesis-generating for longitudinal microvascular progression.
We examined β-adrenergic receptor-mediated vasodilation in skeletal muscle of humans with obesity and normal weight. Results show that despite shifts in the contribution of cyclooxygenase and nitric oxide synthase, β-adrenergic-mediated vasodilation is relatively preserved in young, otherwise healthy adults with obesity. These data highlight the presence of subclinical changes in microvascular control mechanisms early in the obesity process and suggest duration of obesity and/or the addition of primary aging may be necessary for overt dysfunction.
No takes yet. Share an insight, caveat, or question.
Limberg et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: